News and Publications - High Point Clinical Trials Center
 

News and Publications

EVENTS

Find us at one of our upcoming events.

OCT East Coast

May 22-23, 2018

King of Prussia, PA

BIO Intl Conference

June 4-7, 2018

Boston, MA

ENDS Conference

June 5-6, 2018

London, England

ADA 2018

June 22-26, 2018

Orlando, FL

Vaccines and Clinical Trials

July 27-28, 2018

Vancouver, Canada

PRESS RELEASES

See the latest news and information on our clinic.

High Point Clinical Trials Center Offers Free Screenings as Part of International NASH Day

High Point Clinical Trials Center (HPCTC), North Carolina’s premier clinical research facility conducting clinical pharmacology testing of potential metabolic disease therapies, is offering free NASH screenings (nonalcoholic steatohepatitis) to those in the public at elevated risk for this largely underdiagnosed disease…

 

High Point Clinical Trials Center Appoints Melanie Fein, M.D., CPI, DABFM as Medical Director

High Point Clinical Trials Center (HPCTC), the largest clinical pharmacology facility in North Carolina providing early stage clinical research services, proudly welcomes the return of Dr. Melanie Fein as the organization’s Medical Director…

 

HIGH POINT CLINICAL TRIALS CENTER AND AMYNDAS PHARMACEUTICALS ANNOUNCE THE COMPLETION OF THE COMPLEMENT C3 INHIBITOR AMY-101 FIRST IN HUMAN STUDY

High Point Clinical Trial Center (HPCTC) and Amyndas Pharmaceuticals jointly announce the completion of the AMY-101 First in Human (FIH) study, which assessed, safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD)…

 

High Point Clinical Trials Center Announces the Launch of Renal Impairment Clinical Study Offering

High Point Clinical Trials Center (HPCTC) has successfully launched its latest clinical study offering in Renal Impairment. The increasing demand from the pharmaceutical industry to understand the pharmacokinetic impact of novel drugs in renally compromised Patients has prompted…

 

High Point Clinical Trials Center Appoints Clayton Dehn, M.S. as Vice President of Clinical Pharmacology Services

HPCTC is pleased to announce that Clayton Dehn, M.S., has joined the company as Vice President of Clinical Pharmacology Services, reporting to Dr. Lorraine M. Rusch, President. Clayton will lead Clinical Pharmacology Services and act as…

 

High Point Clinical Trials Center Unveils Community Screening Outreach RV

The conversion of a Recreational Vehicle (RV) to a mobile screening and medical information unit will support High Point Clinical Trials Center’s (HPCTC) volunteering initiatives in…

 

High Point Clinical Trials Center Announces Initiative Providing Free Medical Screenings to Community

iCardiac Technologies will assist High Point Clinical Trials Center’s volunteer outreach efforts through donation of electrocardiogram and spirometry equipment.

 

High Point Clinical Trials Center (HPCTC) announced today a joint initiative with iCardiac Technologies, Inc. to support the patient outreach efforts undertaken by…

 

High Point Clinical Trials Center Partners with Verified Clinical Trials to Ensure Participant Safety and Data Quality

High Point Clinical Trials Center announced that it has partnered with Verified Clinical Trials (VCT), the global clinical trials database registry, to ensure

 

PUBLICATIONS

Read the latest publications by our staff and about our clinic.

High Point CTC: Largest Commercial Clinical Research Facility in NC

Published in The High Point Enterprise

 

See the Article

Pathway for NAFLD and NASH drug development in early phase clinical trials

Sabina Paglialunga, Clayton A. Dehn

 

See the Whitepaper

Clinical assessment of hepatic de novo lipogenesis in NAFLD

Sabina Paglialunga, Clayton A. Dehn

 

See the Whitepaper

The Time and Quality Advantages of Electronic VAS Scale vs. Paper VAS Scale Utilization in Studies

Jonathan Austin M.D., Lorraine Rusch Ph.D., Mark Pearson M.D., Margarita Nunez M.D.

 

See the Poster

Opioids for the Treatment of Pain: The Risk of Treating a Multivariate Symptom

Frederick A. Curro, DMD, PhD, FCP

 

The Journal of Clinical Pharmacology 2017, 57(6) 687–689

2017, The American College of Clinical Pharmacology

DOI: 10.1002/jcph.918

 

goo.gl/qVrdl0